COX Nicox SA

Nicox Provides Fourth Quarter 2023 Financial and Business Highlights

Nicox Provides Fourth Quarter 2023 Financial and Business Highlights

Press Release
Nicox Provides Fourth Quarter 2023 Financial and Business Highlights


  • NCX 470 Phase 3 Denali clinical trial 75% randomized
  • Net revenue €1.3 million for fourth quarter 2023 and €4.2 million for the full year 2023, an increase of 29% compared to the full year 2022
  • Cash of €11.9 million on December 31, 2023
  • The Company is financed to June 2024, bas